JAGSNPHARM / NSE / Major Drugs
Jagsonpal Pharmaceuticals
1Y Price Trend
Key Information
Recommendations
Target High301.8
Target Low154.9
Target Mean0
Target Median0
Risk Metrics
Overall RiskBalanced risk
Board Risk34.49
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Golden Cross Confirmed: Do Jagsonpal Pharmaceuticals Ltd's Other Technical Indicators Agree? MarketsMojo
Infinity Holdings confirms no encumbrance of shares in Jagsonpal Pharmaceuticals for FY26 scanx.trade
Jagsonpal Pharmaceuticals extinguishes 16 lakh shares scanx.trade
Jagsonpal Pharmaceuticals Q2 Results Mint
Jagsonpal Pharmaceuticals Upgraded to Sell on Technical Improvements Despite Financial Challenges Markets Mojo
Jagsonpal Pharmaceuticals Downgraded to Strong Sell Amid Technical and Financial Weakness Markets Mojo
Jagsonpal Pharmaceuticals Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals Markets Mojo
Jagsonpal concludes ₹40 crore buyback at ₹250 per share scanx.trade
© SharekeyX | Rusaka Technologies 2024-2026